Impact of Proton Pump Inhibitor Use on 90-Day and 2-Year Postoperative Complications Following Intermedullary Nailing for Intertrochanteric Femur Fractures and ORIF for Proximal Humerus Fractures: A Retrospective Cohort Study

Abstract Purpose: To evaluate the association between proton pump inhibitor (PPI) and postoperative outcomes following intermedullary nailing (IMN) of intertrochanteric femur fractures and open reduction internal fixation (ORIF) of proximal humerus fractures. Methods: Two parallel retrospective cohort analyses were performed using the TriNetX Research Network. Adults (>18 y/o) undergoing IMN for intertrochanteric fractures (n=10,605 per cohort) or ORIF for proximal humerus fractures (n=3,114 per cohort) were grouped by PPI use within 90 days preoperatively. Propensity score matching balanced demographic and clinical characteristics. Outcomes were assessed within 90 days and 2 years postoperatively, reported as risk ratios (RR) with significance as p<0.05. Results: After IMN, PPI use was associated with an increased risk of pulmonary embolism (RR:1.4, p=0.014), acute kidney injury (RR:1.3, p=0.001), and myocardial infarction (RR:1.3, p=0.033 at 90-days follow-up. At 2-years, PPI use was linked to higher rates of deep vein thrombosis (RR:1.1, p=0.031), acute kidney injury (RR:1.2, p=0.006), and pneumonia (RR:1.1, p=0.010). After ORIF, PPI use within 90 days postoperatively was associated with wound disruption (RR:1.7, p=0.05), infection (RR:1.8, p=0.002), deep vein thrombosis (RR:1.8, p=0.026), and pulmonary embolism (RR:2.8, p=0.003). At the 2-years, PPI users experienced increased risks of infection (RR:1.5, p=0.003), DVT (RR:1.8, p=0.002), PE (RR:1.8, p=0.019), UTI (RR:1.3, p=0.022), nonunion (RR:1.7, p=0.004), and malunion (RR:2.1, p=0.025). Conclusion: PPI use is associated with adverse postoperative outcomes following IMN of intertrochanteric fractures and ORIF for proximal humerus fractures. Prospective studies are needed to clarify the causal relationships and isolate the effect of PPI use on postoperative outcomes.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11435174/v1
Primary Topic
Hip and Femur Fractures
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Impact of Proton Pump Inhibitor Use on 90-Day and 2-Year Postoperative Complications Following Intermedullary Nailing for Intertrochanteric Femur Fractures and ORIF for Proximal Humerus Fractures: A Retrospective Cohort Study

Yousef Tanas, Roxana Zaman, Keenan Horani, Kerollos Ibrahim et al.
3 links
Research Square
Hip and Femur Fractures
preprint

Impact of Proton Pump Inhibitor Use on 90-Day and 2-Year Postoperative Complications Following Intermedullary Nailing for Intertrochanteric Femur Fractures and ORIF for Proximal Humerus Fractures: A Retrospective Cohort Study

Yousef Tanas, Roxana Zaman, Keenan Horani, Kerollos Ibrahim, Daniel Cho, Philong Nguyen, William Weiss, Krish Patel, Josh Wang
preprint en

Abstract

Abstract Purpose: To evaluate the association between proton pump inhibitor (PPI) and postoperative outcomes following intermedullary nailing (IMN) of intertrochanteric femur fractures and open reduction internal fixation (ORIF) of proximal humerus fractures. Methods: Two parallel retrospective cohort analyses were performed using the TriNetX Research Network. Adults (>18 y/o) undergoing IMN for intertrochanteric fractures (n=10,605 per cohort) or ORIF for proximal humerus fractures (n=3,114 per cohort) were grouped by PPI use within 90 days preoperatively. Propensity score matching balanced demographic and clinical characteristics. Outcomes were assessed within 90 days and 2 years postoperatively, reported as risk ratios (RR) with significance as p<0.05. Results: After IMN, PPI use was associated with an increased risk of pulmonary embolism (RR:1.4, p=0.014), acute kidney injury (RR:1.3, p=0.001), and myocardial infarction (RR:1.3, p=0.033 at 90-days follow-up. At 2-years, PPI use was linked to higher rates of deep vein thrombosis (RR:1.1, p=0.031), acute kidney injury (RR:1.2, p=0.006), and pneumonia (RR:1.1, p=0.010). After ORIF, PPI use within 90 days postoperatively was associated with wound disruption (RR:1.7, p=0.05), infection (RR:1.8, p=0.002), deep vein thrombosis (RR:1.8, p=0.026), and pulmonary embolism (RR:2.8, p=0.003). At the 2-years, PPI users experienced increased risks of infection (RR:1.5, p=0.003), DVT (RR:1.8, p=0.002), PE (RR:1.8, p=0.019), UTI (RR:1.3, p=0.022), nonunion (RR:1.7, p=0.004), and malunion (RR:2.1, p=0.025). Conclusion: PPI use is associated with adverse postoperative outcomes following IMN of intertrochanteric fractures and ORIF for proximal humerus fractures. Prospective studies are needed to clarify the causal relationships and isolate the effect of PPI use on postoperative outcomes.

Research Square
Houston Methodist (US), Rothman Orthopaedics (US), The University of Texas Medical Branch at Galveston (US)
Good health and well-being
Hip and Femur Fractures
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon